※1 ICCA:International Council of Chemical Associations ※2 LRI (Long-range Research Initiative):化学物質がヒトの健康や環境に及ぼす影響に関する研究の長期的支援活動(https://www.j-lri.org/001-1_1.html)
セッション1 13:00-15:00 LRI活動の説明および日欧米3極のNAMs*3活用に向けた取り組み Kathleen Plotzke, American Chemistry Council (ACC)/Dow, USA Mitsuho Miyahara, Chemical Management Policy Division, METI, Japan Russell Thomas, Center for Computational Toxicology and Exposure, USEPA Elisabet Berggren, Joint Research Centre (JRC), European Commission
セッション3 08:40-10:40 <反復投与毒性、複雑な毒性を予測・評価するためのNAMsの開発> Development of safety prediction system (AI-SHIPS) for industrial chemical compound using AI by METI Kimito Funatsu, Data Science Center, Nara Institute of Science and Technology, Japan
An in vitro battery for developmental neurotoxicity evaluation: from basic science to a regulatory paradigm shift in 21st century Toxicology Ellen Fritsche, University of Dusseldorf, Germany
Internal Threshold of Toxicological Concern (iTTC): Where We Are Today and What Is Possiblein the Near Future Corie Ellison, The Procter &Gamble Company, USA
Potential use of in silico methods for the ecological risk assessment in the chemicalmanagement in Japan Hiroshi Yamamoto, National Institute for Environmental Studies (NIES), Japan
セッション4 11:00-13:00 <内部および外部ばく露評価のためのNAMsの開発> Practical Use of Toxicokinetics Information for a Read-Across of Repeated Dose Toxicity- A Case Study Using Halogenated Aliphatic Compounds Hepatoxicity Category - Shino Kuwa, National Institute of Technology and Evaluation (NITE), Japan
A case study of human risk assessment of a substance using a PBPK modeling technique Jun Abe, Sumitomo Chemical Co., Ltd., Japan
In Vitro Data To Parameterise PBPK Models For Inhalation Exposure (Cefic LRI project B21) Katharina Schwarz, Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM), Germany
Development and Evaluation of a Holistic and Mechanistic Modeling Framework for Chemical Emissions, Fate, Exposure, and Risk Jon Arnot, Arnot Research &Consulting, USA
セッション 5 14:15-16:15 <リスク評価向上への挑戦:NAMsを使った定量的リスク評価 > Integrating New Approach Methodologies into Quantitative Risk Assessments Leslie Recio, ScitoVation LLC, USA
Evaluating the human relevance of chemically induced liver tumors in rodents- Quantitative risk assessment based on the mode of action - Satoki Fukunaga, Sumitomo Chemical Co., Ltd., Japan
Chemical Risk Assessment: Formaldehyde as a Case Example James Sherman, Celanese Corporation, USA
Opportunities for NAMs in an EU regulatory context Carl Westmoreland, Unilever, UK